These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20010156)

  • 61. C-reactive protein, inflammation, and cardiovascular disease: clinical update.
    Ridker PM
    Tex Heart Inst J; 2005; 32(3):384-6. PubMed ID: 16392225
    [No Abstract]   [Full Text] [Related]  

  • 62. [Metabolically designed treatments: from biochemistry to the vessel lining].
    Moulin P
    Rev Med Interne; 2007 Jun; 28 Suppl 1():S12-3. PubMed ID: 17466416
    [No Abstract]   [Full Text] [Related]  

  • 63. Role of C-reactive protein in the assessment of cardiovascular risk.
    Jialal I; Devaraj S
    Am J Cardiol; 2003 Jan; 91(2):200-2. PubMed ID: 12521635
    [No Abstract]   [Full Text] [Related]  

  • 64. C-reactive protein and vascular risk: from March to Jupiter.
    Di Angelantonio E; Cohen A
    Arch Cardiovasc Dis; 2010 Mar; 103(3):139-41. PubMed ID: 20417444
    [No Abstract]   [Full Text] [Related]  

  • 65. C-reactive protein in cardiovascular risk assessment: a review of the evidence.
    Abraham J; Campbell CY; Cheema A; Gluckman TJ; Blumenthal RS; Danyi P
    J Cardiometab Syndr; 2007; 2(2):119-23. PubMed ID: 17684461
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease.
    Osman R; L'Allier PL; Elgharib N; Tardif JC
    Vasc Health Risk Manag; 2006; 2(3):221-37. PubMed ID: 17326329
    [TBL] [Abstract][Full Text] [Related]  

  • 67. C-reactive protein and cardiovascular disease: new insights from an old molecule.
    Hirschfield GM; Pepys MB
    QJM; 2003 Nov; 96(11):793-807. PubMed ID: 14566035
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease.
    Lloyd-Jones DM; Liu K; Tian L; Greenland P
    Ann Intern Med; 2006 Jul; 145(1):35-42. PubMed ID: 16818927
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Using C-reactive protein to assess cardiovascular disease risk.
    Shishehbor MH; Bhatt DL; Topol EJ
    Cleve Clin J Med; 2003 Jul; 70(7):634-40. PubMed ID: 12882386
    [TBL] [Abstract][Full Text] [Related]  

  • 70. C-reactive protein and cardiovascular disease: weighing the evidence.
    Lowe GD; Pepys MB
    Curr Atheroscler Rep; 2006 Sep; 8(5):421-8. PubMed ID: 16901413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview.
    Nakou ES; Liberopoulos EN; Milionis HJ; Elisaf MS
    Curr Vasc Pharmacol; 2008 Oct; 6(4):258-70. PubMed ID: 18855714
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fiber's impact on high-sensitivity C-reactive protein levels in cardiovascular disease.
    Butcher JL; Beckstrand RL
    J Am Acad Nurse Pract; 2010 Nov; 22(11):566-72. PubMed ID: 21054629
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CRP is or is not a reliable marker of ischaemic heart disease?
    Biasucci LM; Giubilato G; Graziani F; Piro M
    Lupus; 2005; 14(9):752-5. PubMed ID: 16218481
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [C-REACTIVE PROTEIN AS AN INDICATOR OF RISK OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ITS CORRECTION].
    Stryuk RI; Sviridova MI; Mkrtumyan AM; Golikova AA
    Klin Med (Mosk); 2016; 94(9):683-7. PubMed ID: 30296044
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of chronic inflammation in cardiovascular mortality of uremic patients.
    Panichi V; Taccola D; Migliori M; Consani C; Giovannini L; Tetta C
    Int J Artif Organs; 2003 Jan; 26(1):12-8. PubMed ID: 12602464
    [No Abstract]   [Full Text] [Related]  

  • 76. Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?
    Lidani KC; Beltrame MH; Luz PR; Sandri TL; Nisihara RM; de Messias-Reaso IJ
    Int J Cardiol; 2015; 190():233-5. PubMed ID: 25920034
    [No Abstract]   [Full Text] [Related]  

  • 77. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum.
    Ridker PM
    Circulation; 2002 Jun; 105(22):2583-5. PubMed ID: 12045159
    [No Abstract]   [Full Text] [Related]  

  • 78. Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy.
    Kaplan RC; Frishman WH
    Heart Dis; 2001; 3(5):326-32. PubMed ID: 11975814
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?
    Hingorani AD; Sofat R; Morris RW; Whincup P; Lowe GD; Mindell J; Sattar N; Casas JP; Shah T
    Eur Heart J; 2012 Sep; 33(18):2258-64. PubMed ID: 22766581
    [No Abstract]   [Full Text] [Related]  

  • 80. New blood test to measure heart attack risk: C-reactive protein.
    Duffy JR; Salerno M
    J Cardiovasc Nurs; 2004; 19(6):425-9. PubMed ID: 15529066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.